Analyst Conference Summaries

Biotechnology Investor Aids


conference date: May 9, 2019 @ 1:30 PM Pacific Time

Verastem Cancer Therapy Should Get Traction, Raise Stock Price

Q4 2018
Q1 2019
March 12, 2019 May 9, 2019    
March 13, 2018
May 3, 2018
August 8, 2018
Nov. 7, 2018

Verastem (VSTM) is a commercial-stage biotechnology company specializing in cancer therapies.

Verastem web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2019 William P. Meyers